Clinical Trial Update: Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating docetaxel/cisplatin induction therapy followed by concurrent chemoradiotherapy, or concurrent chemoradiotherapy with consolidati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Non-Small-Cell Lung Carcinoma | Phase 2 | Status: TERMINATED